DPDoctor's PassportEducation
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
RapidMLAMSRAGP

Non-accidental ocular injury

Essential points for quick revision.

!
Treat injury and protect the child

An unexplained eye injury in a child can accompany serious intracranial injury or continuing danger, even when external signs are modest.

Action: Stabilise acute illness, obtain urgent senior paediatric and ophthalmic help, and activate the safeguarding pathway without waiting for diagnostic certainty.

Synopsis

Recognise eye findings that warrant safeguarding assessment, protect the child while treating injury, and interpret retinal evidence without overstating what it establishes.

  • A safeguarding concern is a reason to assess and act; it is not proof of a particular perpetrator.
  • No retinal finding alone is pathognomonic of abusive head trauma.
  • Numerous bilateral haemorrhages across retinal layers and into the periphery increase concern in the relevant clinical context.

Key red flags

Reduced consciousness, seizures, apnoea or repeated vomiting alongside unexplained ocular findings.

Investigation priorities

01
Early specialist examination of both eyesFirst step

Identify and describe ocular injury before transient findings disappear.

Management branches

Immediate clinical careStabilise before aetiological debate

The child has acute illness or a potentially sight-threatening injury.

  1. Address airway, breathing, circulation and neurological emergencies with urgent senior paediatric support.
  2. Provide the specific emergency treatment required by the ocular injury while seeking ophthalmic advice.
Open full textbook Answer 2 questions
Sources and review status6 sources · checked 7 Sept 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 7 Sept 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom